Back

Mavacamten vs. alcohol septal ablation in obstructive hypertrophic cardiomyopathy: an echocardiography-derived pressure-volume analysis

30 August 2026 (11:25 - 11:35)
Organised by: Logo
Congress Presentation Part of: Contemporary assessment of diastolic function and HFpEF phenotypes Systolic and Diastolic Function ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Jan-Christian Reil

(Germany)

5 More presentations in this session

Presentation thumbnail
Discriminatory and prognostic value of MRI-derived myocardial work efficiency in heart failure with preserved ejection fraction: beyond global longitudinal strain
Miss L. Zhu (Beijing, CN)
Abstract Slides
Presentation thumbnail
Prognostic value of disproportionate left atrial myopathy in patients with heart failure
Doctor M. Kambayashi (Sapporo, JP)
Abstract Slides Video
Presentation thumbnail
The relationship between beat-to-beat variability in left ventricular inflow velocity and left ventricular filling pressure in patients with atrial fibrillation.
Assistant Professor T. Kitano (Tsu, JP)
Abstract Slides
Presentation thumbnail
Prognostic correlates of strain stress echocardiography
Doctor R. Arbucci (Caba, AR)
Abstract Slides Video
Presentation thumbnail
Noninvasive identification of coronary vasospasm by hyperventilation stress echocardiography with a multi-marker protocol
Doctor S. Dedic (Belgrade, RS)
Abstract Slides Video

Access the full session

Session thumbnail
Contemporary assessment of diastolic function and HFpEF phenotypes
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 11:25 CET
You may be interested in
thumbnail
Congress Presentation
The cardiac myosin inhibitor mavacamten reduces even extreme left ventricular outflow gradient in obstructive hypertrophic cardiomyopathy already after one week of treatment
12 December 2024
thumbnail
Congress Presentation
Temporal trends, patient characteristics and hospital volume outcomes after alcohol septal ablation and septal myectomy for treatment of obstructive hypertrophic cardiomyopathy
25 August 2023
thumbnail
Congress Presentation
Pursuing the non-invasive assessment of cardiac contractility: the added value of pressure-area-strain loop analysis in volume overload-induced heart failure
11 December 2020
thumbnail
Congress Presentation
Relationship between mitral valve echocardiographic parameters and interventional septal reduction therapy success in patients with hypertrophic obstructive cardiomyopathy - a pilot study
10 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources